India Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to the India drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices in India

Scope

-The report provides drug delivery devices information broken down into detailed categories and segments in India.
-Total revenues, products sold, end users, and average pricing.
-Market shares of all the key competitors.
-Key pipeline products that are set to shape the market, broken down by sector.
-Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
-Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
-Key mergers and acquisitions, partnerships, private equity investments and IPOs.
-Customer, hospitals and physicians data.

Reasons to buy

-Gain a strong understanding of the drug delivery devices market in India.
-Evaluate and compare the attractiveness of the market in the country.
-Identify growth segments and opportunities in each industry sector within the country.
-Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
-Analyze the competitiveness of the market in the country and identify hotspots.
-Develop strategies based on the latest product, brand, expansion and research and development news in the country.
-Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
-Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Table of Contents:

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of Markets Covered in This Report 10
3.1 Drug delivery devices 10
3.2 Needle-free Injections 10
3.3 Inhalation Systems 10
3.3.1 Metered Dose Inhaler 10
3.3.2 Dry powder inhaler 10
3.4 Infusion Systems 10
3.4.1 Infusion pumps 10
3.4.2 Syringe pumps 11
3.4.3 Disposable Infusion sets 11
4 Healthcare Sector Review 12
4.1 Healthcare Expenditure 12
4.2 Healthcare Infrastructure 14
4.2.1 Healthcare Personnel Data 15
4.2.2 Healthcare Facilities Data 16
4.3 Healthcare Policy 17
5 Regulation System 18
5.1 Medical Equipment Approval 18
5.2 Central Drugs Authority of India (CDAI) 19
5.3 Medical Device Regulatory Authority of India (MDRAI) 19
5.4 Classification of medical devices 19
5.4.1 Registration Period 20
6 Pricing and Reimbursement 21
6.1 Pricing and Reimbursement 21
7 Distribution Structure 22
7.1 Distribution Structure 22
8 Drug Delivery Devices In India 23
8.1 Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 23
8.2 Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015 24
8.3 Drug Delivery Devices, India, Category Volume (Units), 2000-2015 28
8.4 Drug Delivery Devices, India, Company Share (2006-2007) 31
9 Infusion Systems In India 32
9.1 Infusion Systems Overall Revenue (2000-2015) 32
9.2 Infusion Systems Overall Volume (2000-2015) 34
9.3 Infusion Systems Average Price (2000-2015) 35
9.4 Infusion Systems Distribution Share (2007-2008) 36
9.5 Infusion Systems, India, Company Share (2006-2007) 37
10 Inhalation Systems In India 38
10.1 Inhalation Systems Overall Revenue (2000-2015) 38
10.2 Inhalation Systems Overall Volume (2000-2015) 40
10.3 Inhalation Systems Average Price (2000-2015) 42
10.4 Inhalation Systems Distribution Share (2007-2008) 43
10.5 Inhalation Systems, India, Company Share (2006-2007) 44
11 Overview of Key Companies in India Drug Delivery Devices Market 45
11.1 AstraZeneca PLC Company Profile 45
11.1.1 Company Overview 45
11.2 GlaxoSmithKline plc Company Profile 45
11.2.1 Company Overview 45
11.3 Boehringer Ingelheim GmbH Company Profile 46
11.3.1 Company Overview 46
11.3.2 Value Chain Analysis 47
11.3.2.1 Manufacturing 47
11.3.2.2 Product Development 48
11.3.2.3 Sales and Marketing 48
11.4 Novartis AG 49
11.4.1 Company Overview 49
11.5 B. Braun Melsungen AG Company Profile 49
11.5.1 Company Overview 49
11.5.2 Value Chain Analysis 50
11.5.2.1 Manufacturing 50
11.5.2.2 Product Development 51
11.5.2.3 Research and Development 52
11.5.2.4 Sales and Marketing 52
11.6 Fresenius SE 53
11.6.1 Company Overview 53
11.7 Cardinal Health, Inc. Company Profile 54
11.7.1 Company Overview 54
11.7.2 Value Chain Analysis 54
11.7.2.1 Manufacturing 55
11.7.2.2 Product Development 55
11.7.2.3 Sales and Marketing 56
11.8 Baxter International Inc. Company Profile 57
11.8.1 Company Overview 57
11.8.2 Value Chain Analysis 58
11.8.2.1 Manufacturing 58
11.8.2.2 Product Development 58
11.8.2.3 Sales and Marketing 59
11.9 Hospira, Inc. Company Profile 61
11.9.1 Company Overview 61
11.9.2 Value Chain Analysis 61
11.9.2.1 Manufacturing 62
11.9.2.2 Product Development 62
11.9.2.3 Research and Development 63
11.9.2.4 Sales and Marketing 63
11.9.3 Hospira, Inc. Pipeline Products 64
11.9.3.1 Hospira, Inc. Pipeline Products by Equipment Type 64
11.9.3.2 Hospira, Inc. Pipeline Products by Development Stage 64
11.9.3.3 Hospira, Inc. Pipeline Products by Therapy Area 64
11.10 Consort Medical plc Company Profile 65
11.10.1 Company Overview 65
11.10.2 Value Chain Analysis 65
11.10.2.1 Manufacturing 66
11.10.2.2 Product Development 66
11.10.2.3 Sales and Marketing 66
11.10.3 Consort Medical plc Pipeline Products 67
11.10.3.1 Consort Medical plc Pipeline Products By Equipment Type 67
11.10.3.2 Consort Medical plc Pipeline Products By Development Stage 67
11.10.3.3 Consort Medical plc Pipeline Products By Therapy Area 67
11.11 CONMED Corporation 68
11.11.1 Company Overview 68
11.12 JMS CO., LTD. 68
11.12.1 Company Overview 68
11.13 Trivitron Group of Companies 68
11.13.1 Company Overview 68
11.14 Schiller Healthcare India Pvt. Ltd. 69
11.14.1 Company Overview 69
11.15 AKAS Medical Company Profile 70
11.15.1 Company Overview 70
11.16 Emco Meditek Private Limited Company Profile 70
11.16.1 Company Overview 70
11.17 Lakhani Medicare Pvt. Ltd. Company Profile 70
11.17.1 Company Overview 70
11.18 Monarch Surgical Industries Company Profile 71
11.18.1 Company Overview 71
11.19 Plenum Technologies Private Limited Company Profile 71
11.19.1 Company Overview 71
11.20 Vital Biosystems Pvt. Ltd. Company Profile 71
11.20.1 Company Overview 71
12 Financial Deals Landscape 72
12.1 Partnerships 72
12.1.1 Teikoku Pharma Enters Into an Agreement with Eisai 72
13 Appendix 73
13.1 Global Markets Direct Research Methodology 73
13.2 Coverage 74
13.3 Secondary Research 74
13.4 Primary Research 75
13.5 Models 75
13.6 Forecasts 76
13.7 Expert Panel Validation 76
13.8 Currency Conversion 77
13.9 Contact Us 78
13.10 Disclaimer 78

1.1 List of Tables
Table 1: Number of Doctors by Specialty in India, 2000-2006 15
Table 2: Wards by Specialty in India, 2000-2006 16
Table 3: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 23
Table 4: Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015 24
Table 5: Drug Delivery Devices, India, Portfolio Analysis, 2000-2015 25
Table 6: Drug Delivery Devices, India, Overall Revenue ($ mn), Historic, 2000-2008 26
Table 7: Drug Delivery Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015 27
Table 8: Drug Delivery Devices, India, Category Volume (Units), 2000-2015 28
Table 9: Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2008 29
Table 10: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2008-2015 30
Table 11: Drug Delivery Devices, India, Company Share by Revenue ($ mn), 2006-2007 31
Table 12: Infusion Systems, India, Revenue ($ mn) by Segment, Historic, 2000-2008 32
Table 13: Infusion Systems, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 33
Table 14: Infusion Systems, India, Volume (Units), Historic, 2000-2008 34
Table 15: Infusion Systems, India, Volume (Units), Forecast, 2008-2015 34
Table 16: Infusion Systems, India, Average Price ($), Historic, 2000-2008 35
Table 17: Infusion Systems, India, Average Price ($), Forecast, 2008-2015 35
Table 18: Infusion Systems, India, Distribution Share by Revenue ($mn), 2007-2008 36
Table 19: Infusion Systems, India, Company Share by Revenue ($ mn), 2006-2007 37
Table 20: Inhalation Systems, India, Revenue ($ mn) by Segment, Historic, 2000-2008 38
Table 21: Inhalation Systems, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 39
Table 22: Inhalation Systems, India, Volume (Units), Historic, 2000-2008 40
Table 23: Inhalation Systems, India, Volume (Units), Forecast, 2008-2015 41
Table 24: Inhalation Systems, India, Average Price ($), Historic, 2000-2008 42
Table 25: Inhalation Systems, India, Average Price ($), Forecast, 2008-2015 42
Table 26: Inhalation Systems, India, Distribution Share by Revenue ($mn), 2007-2008 43
Table 27: Inhalation Systems, India, Company Share by Revenue ($ mn), 2006-2007 44
Table 28: Hospira, Inc. Pipeline Products by Equipment Type 64
Table 29: Hospira, Inc. Pipeline Products By Development Stage 64
Table 30: Hospira, Inc. Pipeline Products By Therapy Area 64
Table 31: Consort Medical plc Pipeline Products by Equipment Type 67
Table 32: Consort Medical plc Pipeline Products By Development Stage 67
Table 33: Consort Medical plc Pipeline Products By Therapy Area 67
Table 34: Teikoku Pharma Enters Into An Agreement With Eisai 72
Table 35: USD to Local Currency, Average Exchange Rate 2008 77

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in India, 2000-2005 13
Figure 2: Private Expenditure on Health by Source, 2005 14
Figure 3: Proposed Medical Equipment Classification in India, 2005 20
Figure 4: Drug Delivery Devices Cross Country Comparison, Revenue ($ mn), 2000-2015 23
Figure 5: Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015 24
Figure 6: Drug Delivery Devices, India, Portfolio Analysis, 2000-2015 25
Figure 7: Drug Delivery Devices, India, Overall Revenue ($ mn), Historic, 2000-2008 26
Figure 8: Drug Delivery Devices, India, Overall Revenue ($ mn), Forecast, 2008-2015 27
Figure 9: Drug Delivery Devices, India, Category Volume (Units), 2000-2015 28
Figure 10: Drug Delivery Devices, India, Category Volume (Units), Historic, 2000-2008 29
Figure 11: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2008-2015 30
Figure 12: Drug Delivery Devices, India, Company Share (%), 2007 31
Figure 13: Infusion Systems, India, Revenue ($ mn) by Segment, Historic, 2000-2008 32
Figure 14: Infusion Systems, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 33
Figure 15: Infusion Systems, India, Company Share (%), 2007 37
Figure 16: Inhalation Systems, India, Revenue ($ mn) by Segment, Historic, 2000-2008 38
Figure 17: Inhalation Systems, India, Revenue ($ mn) by Segment, Forecast, 2008-2015 39
Figure 18: Inhalation Systems, India, Volume (Units), Historic, 2000-2008 40
Figure 19: Inhalation Systems, India, Volume (Units), Forecast, 2008-2015 41
Figure 20: Inhalation Systems, India, Company Share (%), 2007 44
Figure 21: Boehringer Ingelheim GmbH Value Chain Analysis 47
Figure 22: B. Braun Melsungen AG Value Chain Analysis 50
Figure 23: Cardinal Health, Inc. Value Chain Analysis 54
Figure 24: Baxter International Inc. Value Chain Analysis 58
Figure 25: Hospira, Inc. Value Chain Analysis 61
Figure 26: Consort Medical plc Value Chain Analysis 65
Figure 27: Global Markets Direct Methodology 73

To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/Market-Research-Reports/India-Drug-Delivery-Devices-Investment-Opportunities-Analysis-and-Forecasts.html

Or

Contact us at:
Bharat Book Bureau
Tel: +91 22 2757 8668
Fax: +91 22 2757 9131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com